217 related articles for article (PubMed ID: 30470772)
21. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
22. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
[TBL] [Abstract][Full Text] [Related]
23. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.
Li X; Ma TK; Wang P; Shi H; Hai S; Qin Y; Zou Y; Zhu WT; Li HM; Li YN; Yin L; Xu YY; Yang Q; Zhang S; Ding H
Cell Death Dis; 2024 Jun; 15(6):398. PubMed ID: 38844470
[TBL] [Abstract][Full Text] [Related]
24. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
[TBL] [Abstract][Full Text] [Related]
25. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
26. NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses.
Jiang F; Liu GS; Dusting GJ; Chan EC
Redox Biol; 2014; 2():267-72. PubMed ID: 24494202
[TBL] [Abstract][Full Text] [Related]
27. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
[TBL] [Abstract][Full Text] [Related]
28. NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling.
Ryu D; Lee JH; Kwak MK
Arch Pharm Res; 2020 Dec; 43(12):1297-1310. PubMed ID: 33242180
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-β1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo.
Peshavariya HM; Chan EC; Liu GS; Jiang F; Dusting GJ
J Cell Mol Med; 2014 Jun; 18(6):1172-83. PubMed ID: 24629065
[TBL] [Abstract][Full Text] [Related]
30. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib.
Wang D; Wei Y; Xu L; Zhang J
Adv Rheumatol; 2023 May; 63(1):22. PubMed ID: 37194022
[TBL] [Abstract][Full Text] [Related]
31.
Peng LY; An L; Sun NY; Ma Y; Zhang XW; Liu WH; Liu BL; Li P; Chen J
Am J Chin Med; 2019; 47(5):1113-1131. PubMed ID: 31352786
[TBL] [Abstract][Full Text] [Related]
32. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
Liu RM; Choi J; Wu JH; Gaston Pravia KA; Lewis KM; Brand JD; Mochel NS; Krzywanski DM; Lambeth JD; Hagood JS; Forman HJ; Thannickal VJ; Postlethwait EM
J Biol Chem; 2010 May; 285(21):16239-47. PubMed ID: 20228065
[TBL] [Abstract][Full Text] [Related]
33. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
[TBL] [Abstract][Full Text] [Related]
34. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
35. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
[TBL] [Abstract][Full Text] [Related]
37. Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Pourgholamhossein F; Rasooli R; Pournamdari M; Pourgholi L; Samareh-Fekri M; Ghazi-Khansari M; Iranpour M; Poursalehi HR; Heidari MR; Mandegary A
Food Chem Toxicol; 2018 Feb; 112():39-46. PubMed ID: 29273418
[TBL] [Abstract][Full Text] [Related]
38. Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease.
Hu F; Xue M; Li Y; Jia YJ; Zheng ZJ; Yang YL; Guan MP; Sun L; Xue YM
J Diabetes Res; 2018; 2018():3405695. PubMed ID: 29854821
[TBL] [Abstract][Full Text] [Related]
39. Activation of ERK1/2-mTORC1-NOX4 mediates TGF-β1-induced epithelial-mesenchymal transition and fibrosis in retinal pigment epithelial cells.
Kim SJ; Kim YS; Kim JH; Jang HY; Ly DD; Das R; Park KS
Biochem Biophys Res Commun; 2020 Aug; 529(3):747-752. PubMed ID: 32736702
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways.
Kocak A; Ural C; Harmanci D; Oktan MA; Afagh A; Sarioglu S; Yilmaz O; Birlik M; Akdogan GG; Cavdar Z
Hum Exp Toxicol; 2022; 41():9603271211065975. PubMed ID: 35187969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
